Results 41 to 50 of about 1,184,867 (159)

Chemoradiation of locally advanced biliary cancer: A PRISMA‐compliant systematic review

open access: yesCancer Medicine, Volume 13, Issue 23, December 2024.
This is a systematic review of the current evidence on “modern” chemoradiation for primary or recurrent unresectable biliary tract cancers. We have critically compared chemoradiation outcomes with those of other treatment options, seeking to determine whether specific chemoradiation modalities provide distinct advantages in terms of treatment efficacy ...
Silvia Bisello   +14 more
wiley   +1 more source

Prevalence and Significance of AGR2 Expression in Human Cancer

open access: yesCancer Medicine, Volume 13, Issue 21, November 2024.
ABSTRACT Backround Anterior gradient 2 (AGR2) is a resident endoplasmic reticulum (ER) protein with a vital role in embryonal development, mucus maturation, tissue regeneration, and wound healing. Methods To determine the prevalence and clinical significance of AGR2 expression in cancer, a tissue microarray containing 14,966 tumors from 134 different ...
Nina Schraps   +31 more
wiley   +1 more source

New molecular mediators in tumor angiogenesis [PDF]

open access: yes, 2007
Angiogenesis is essential for tumor growth and progression. It has been demonstrated that tumor growth beyond a size 1 to 2 mm3 requires the induction of new vessels.
Jonas, Dietger   +2 more
core   +1 more source

Septin 9 expression regulates ‘don't eat me’ signals and identifies an immune–epithelial class of intrahepatic cholangiocarcinoma

open access: yesMolecular Oncology, Volume 18, Issue 10, Page 2369-2392, October 2024.
Septin 9 is identified as a regulator of EMT and the host immune response. Intrahepatic cholangiocarcinoma (iCCA) was categorized into two groups: (1) ‘immune–epithelial’, with high expression of septin 9 and ‘don't eat me’ signal genes regulated by IFNγ/STAT1; and (2) ‘mesenchymal–ECM’, with high expression of vimentin, MMP7 and TIMP1.
Ting ting Cai   +9 more
wiley   +1 more source

Newsletter: A Report to the Physicians of Texas

open access: yes, 1980
Quarterly newsletter from the University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute discussing cancer care and research to inform physicians of recent developments in the ...
McBurney, Marcia K.   +1 more
core   +1 more source

Newsletter: A Report to the Physicians of Texas

open access: yes, 1982
Quarterly newsletter from the University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute discussing cancer care and research to inform physicians of recent developments in the ...
Eisen, Leslie L.   +1 more
core   +2 more sources

Tumor-induced myeloid cell plasticity toward lymphatic endothelium [PDF]

open access: yes, 2009
Tumor-associated lymphangiogenesis contributes to tumor progression by regulating interstitial fluid pressure, transporting immune cells to the tumor site and providing a route for metastatic dissemination.
Baeriswyl, Vanessa
core   +1 more source

CT Texture Analysis of Perihilar Cholangiocarcinoma—Associations With Tumor Grading, Tumor Markers and Clinical Outcome

open access: yesCancer Reports, Volume 7, Issue 9, September 2024.
ABSTRACT Background Texture analysis derived from computed tomography (CT) may provide clinically relevant imaging biomarkers associated with tumor histopathology. Perihilar cholangiocarcinoma is a malignant disease with an overall poor prognosis. Aims The present study sought to elucidate possible associations between texture features derived from CT ...
Jakob Leonhardi   +9 more
wiley   +1 more source

Staining pattern of specific and cross‐reacting Melan‐A antibodies: A comparative study on 15,840 samples from 133 human tumor types

open access: yesAPMIS, Volume 132, Issue 7, Page 479-491, July 2024.
The Melan‐A (melanocyte antigen) protein, also termed ‘melanoma antigen recognized by T cells 1’ (MART‐1) is a protein with unknown function whose expression is specific for the melanocyte lineage. Antibodies against Melan‐A are thus used for identifying melanocytic tumors, but some Melan‐A antibodies show an additional – diagnostically useful – cross ...
Shiva Boroojerdi   +29 more
wiley   +1 more source

Reoperation for post hepatectomy complications

open access: yesANZ Journal of Surgery, Volume 94, Issue 4, Page 660-666, April 2024.
Hepatectomy is associated with complications that may require return to theatre. However, there is a paucity in the literature identifying risk factors resulting in reoperation post‐hepatectomy. This paper has demonstrated that performing an additional major non‐hepatic procedure concurrent with the hepatectomy is a risk factor for return to theatre ...
Sam Yu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy